X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (106) 106
humans (87) 87
index medicus (87) 87
chemotherapy (58) 58
male (55) 55
female (54) 54
cancer (50) 50
middle aged (49) 49
aged (47) 47
colorectal cancer (44) 44
survival (38) 38
adult (37) 37
aged, 80 and over (31) 31
colorectal neoplasms - pathology (29) 29
prognosis (28) 28
colorectal neoplasms - drug therapy (26) 26
metastasis (26) 26
treatment outcome (24) 24
cetuximab (23) 23
colorectal neoplasms - mortality (23) 23
care and treatment (22) 22
mutation (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
antineoplastic agents - therapeutic use (20) 20
survival rate (19) 19
medicine, general & internal (18) 18
survival analysis (18) 18
analysis (17) 17
colorectal neoplasms - genetics (17) 17
oxaliplatin (17) 17
fluorouracil (16) 16
disease-free survival (15) 15
leucovorin (15) 15
research (15) 15
1st-line treatment (14) 14
australia (14) 14
neoplasm metastasis (14) 14
registries (14) 14
clinical trials (13) 13
metastases (13) 13
retrospective studies (13) 13
abridged index medicus (12) 12
colorectal neoplasms - therapy (12) 12
therapy (12) 12
young adult (12) 12
carcinoma (11) 11
colon-cancer (11) 11
hematology, oncology and palliative medicine (11) 11
irinotecan (11) 11
neoplasm staging (11) 11
quality of life (11) 11
diagnosis (10) 10
genetic aspects (10) 10
health aspects (10) 10
patient outcomes (10) 10
patients (10) 10
adolescent (9) 9
antibodies, monoclonal - therapeutic use (9) 9
cancer therapies (9) 9
combined modality therapy (9) 9
follow-up studies (9) 9
proportional hazards models (9) 9
surgery (9) 9
trial (9) 9
bevacizumab (8) 8
cisplatin (8) 8
colorectal carcinoma (8) 8
combination (8) 8
drug therapy (8) 8
health care sciences & services (8) 8
kaplan-meier estimate (8) 8
kras (8) 8
liver neoplasms - secondary (8) 8
medicine & public health (8) 8
south australia - epidemiology (8) 8
adenocarcinoma (7) 7
biomarkers (7) 7
biomarkers, tumor - genetics (7) 7
colorectal (7) 7
fluorouracil - therapeutic use (7) 7
open-label (7) 7
panitumumab (7) 7
proto-oncogene proteins b-raf - genetics (7) 7
proto-oncogene proteins p21 - genetics (7) 7
ras mutations (7) 7
receptor, epidermal growth factor - antagonists & inhibitors (7) 7
risk factors (7) 7
south australia (7) 7
antibodies, monoclonal, humanized (6) 6
chemoradiotherapy (6) 6
combination chemotherapy (6) 6
death (6) 6
docetaxel (6) 6
expression (6) 6
fluorouracil - administration & dosage (6) 6
gastroenterology and hepatology (6) 6
gemcitabine (6) 6
gene mutations (6) 6
incidence (6) 6
leucovorin - therapeutic use (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2018, Volume 29, Issue suppl_7
Journal Article
Internal Medicine Journal, ISSN 1444-0903, 11/2018, Volume 48, Issue 11, p. 1415
Journal Article
Internal Medicine Journal, ISSN 1444-0903, 11/2018, Volume 48, Issue 11, pp. 1415 - 1416
Journal Article
Internal Medicine Journal, ISSN 1444-0903, 11/2018, Volume 48, Issue 11, pp. 1415 - 1416
Journal Article
Internal Medicine Journal, ISSN 1444-0903, 11/2018, Volume 48, Issue 11, pp. 1415 - 1416
Journal Article
Internal Medicine Journal, ISSN 1444-0903, 11/2018, Volume 48, Issue 11, pp. 1415 - 1416
Journal Article
Internal medicine journal, 11/2018, Volume 48, Issue 11, p. 1415
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 20, pp. 1919 - 1929
Journal Article
Cancer Forum, ISSN 0311-306X, 04/2018, Volume 42, Issue 1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 24, pp. 2342 - 2350
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 17, pp. 1757 - 1765
Journal Article
JAMA, ISSN 0098-7484, 10/2010, Volume 304, Issue 16, pp. 1812 - 1820
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2012, Volume 30, Issue 29, pp. 3588 - 3595
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 08/2019, Volume 14, Issue 8, pp. 1440 - 1446
Introduction: There is substantial variability in survival and response outcomes for patients using immune check-point inhibitors (ICIs), and predictive... 
MULTICENTER | Immune checkpoint inhibitor | OPEN-LABEL | DOCETAXEL | Prognostic | CHEMOTHERAPY | CHECKPOINT INHIBITORS | ONCOLOGY | RESPIRATORY SYSTEM | marker | Predictive | 1ST-LINE | Atezolizumab
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, pp. e0135599 - e0135599
Importance The EGFR inhibitors (EGFR-I) cetuximab and panitumumab and the angiogenesis inhibitors (AIs) bevacizumab and aflibercept have demonstrated varying... 
PHASE-III TRIAL | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS CETUXIMAB TREATMENT | BEVACIZUMAB | RAS MUTATIONS | MULTIDISCIPLINARY SCIENCES | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | KRAS WILD-TYPE | FLUOROURACIL | Capecitabine - administration & dosage | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Fluorouracil - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Leucovorin - therapeutic use | Molecular Targeted Therapy - methods | Recombinant Fusion Proteins - administration & dosage | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Survival Rate | Treatment Outcome | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mutation | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Care and treatment | Chemotherapy | Analysis | Colorectal cancer | Metastasis | Angiogenesis inhibitors | Cancer | Schedules | Toxicity | Bias | Colorectal carcinoma | Clinical trials | Oncology | Systematic review | Cancer therapies | Subgroups | Bevacizumab | Metastases | Angiogenesis | Oxaliplatin | Epidermal growth factor | Effectiveness | Epidermal growth factor receptors | Patients | Survival | Meta-analysis | Studies | Irinotecan | Inhibitors | Response rates | Quality assessment | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.